动态对比增强磁共振淋巴管成像:影像表现分类及其与患者管理相关性
回顾性分析2012年6月至2017年8月一家三级儿科医院25例DCMRL检查(23例患者,中位年龄4岁),技术成功率92%(23/25)。按中央传导淋巴管(CCL)状态及替代淋巴通路将表现分为3型,各型对应不同管理选择:1型继续保守管理,2型避免胸导管结扎或栓塞而采用Denver®分流或淋巴静脉吻合,3型需评估中心静脉压升高。
要点
- DCMRL按CCL显影及替代通路分为1型(CCL正常无替代通路)、2型(CCL部分或完全未显影伴对比剂反流入替代通路)、3型(CCL正常伴替代通路额外充盈)。
- 2型提示CCL梗阻,应避免胸导管结扎或栓塞,可考虑Denver®分流或淋巴静脉吻合。
- 3型需评估中心静脉压升高作为淋巴反流原因,管理包括Denver®分流、淋巴静脉吻合、胸导管结扎或栓塞。
核心结论
- DCMRL是理解中央传导淋巴管异常的一种发展中的影像技术,其影像表现分类可能有助于指导管理方案的选择。
研究设计与样本
- 回顾性研究,纳入2012年6月至2017年8月一家三级儿科医院接受DCMRL的23例患者(9例男性、13例女性、1例性别不明),中位年龄4岁(范围1个月至29岁),共25次DCMRL检查;对影像表现进行回顾、分类并分析对患者管理的影响。
关键影像表现/征象
- 1型:中央传导淋巴管(CCL)正常,无替代淋巴通路(n=5)。
- 2型:CCL部分(2a)或完全(2b)未显影,对比剂反流入替代通路(n=10)。
- 3型:CCL正常,替代通路额外充盈(n=8)。
诊断标准与关键数值
- DCMRL技术成功率为23/25(92%)。
- 影像表现基于中央传导淋巴管(CCL)状态和替代淋巴通路分为1型、2型(2a部分未显影/2b完全未显影)和3型。
临床应用与阅片要点
- 1型DCMRL患者(n=5)予以 reassuring 并继续保守管理。
- 2型患者(n=10)有CCL梗阻证据,避免胸导管结扎或栓塞,采用Denver®分流或淋巴静脉吻合等选项。
- 3型患者(n=8)评估中心静脉压升高作为淋巴反流原因,管理包括Denver®分流、淋巴静脉吻合、胸导管结扎或栓塞。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To review the technical aspects and categorize the imaging findings of dynamic contrast enhanced magnetic resonance lymphangiography (DCMRL) and correlate the findings with patient management options.
MATERIALS AND METHODS: A retrospective review of patients who underwent DCMRL between June 2012 and August 2017 at a tertiary care paediatric hospital was performed. Twenty-five DCMRL studies were performed in 23 patients (9 males, 13 females, 1 ambiguous gender) with a median age of 4 years (range: 1 month-29 years). DCMRL imaging findings were reviewed, categorized and the impact on patient management was studied.
RESULTS: DCMRL was technically successful in 23/25 (92%) studies. DCMRL findings were categorized based on the status of central conducting lymphatics (CCL) and alternate lymphatic pathways as follows: Type 1 - normal CCL with no alternate lymphatic pathways, Type 2 - partial (2a) or complete (2b) non-visualization of CCL with reflux of contrast into alternate pathways and Type 3 - normal CCL with additional filling of alternate pathways. Type 1 DCMRL patients (n = 5) were reassured and conservative management was continued, Type 2 patients (n = 10) had evidence of CCL obstruction hence thoracic duct ligation or embolization was avoided and other options such as lymphatic fluid diversion using Denver® shunt or lympho-venous anastomosis were used, and Type 3 patients (n = 8) were evaluated for elevated central venous pressure as a cause of lymphatic backflow in addition to Denver® shunt, lympho-venous anastomosis, thoracic duct ligation or embolization.
CONCLUSION: DCMRL is an evolving imaging technique for understanding abnormalities of the central conducting lymphatics. Categorization of imaging findings may be helpful in guiding selection of management options.
引用
- Pimpalwar S, Chinnadurai P, Chau A, et al. Dynamic contrast enhanced magnetic resonance lymphangiography: Categorization of imaging findings and correlation with patient management. Eur J Radiol. 2018. PMID: 29571786. doi:10.1016/j.ejrad.2018.02.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。